Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nucleic Acids Res ; 52(10): 6079-6091, 2024 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-38661215

RESUMO

CRISPR-Cas systems can be utilized as programmable-spectrum antimicrobials to combat bacterial infections. However, how CRISPR nucleases perform as antimicrobials across target sites and strains remains poorly explored. Here, we address this knowledge gap by systematically interrogating the use of CRISPR antimicrobials using multidrug-resistant and hypervirulent strains of Klebsiella pneumoniae as models. Comparing different Cas nucleases, DNA-targeting nucleases outperformed RNA-targeting nucleases based on the tested targets. Focusing on AsCas12a that exhibited robust targeting across different strains, we found that the elucidated modes of escape varied widely, restraining opportunities to enhance killing. We also encountered individual guide RNAs yielding different extents of clearance across strains, which were linked to an interplay between improper gRNA folding and strain-specific DNA repair and survival. To explore features that could improve targeting across strains, we performed a genome-wide screen in different K. pneumoniae strains that yielded guide design rules and trained an algorithm for predicting guide efficiency. Finally, we showed that Cas12a antimicrobials can be exploited to eliminate K. pneumoniae when encoded in phagemids delivered by T7-like phages. Altogether, our results highlight the importance of evaluating antimicrobial activity of CRISPR antimicrobials across relevant strains and define critical parameters for efficient CRISPR-based targeting.


Assuntos
Sistemas CRISPR-Cas , Klebsiella pneumoniae , RNA Guia de Sistemas CRISPR-Cas , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/efeitos dos fármacos , RNA Guia de Sistemas CRISPR-Cas/genética , RNA Guia de Sistemas CRISPR-Cas/metabolismo , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Endodesoxirribonucleases/metabolismo , Endodesoxirribonucleases/genética , Infecções por Klebsiella/tratamento farmacológico , Infecções por Klebsiella/microbiologia , Proteínas Associadas a CRISPR/metabolismo , Proteínas Associadas a CRISPR/genética , Antibacterianos/farmacologia , Farmacorresistência Bacteriana Múltipla/genética , Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas , Genoma Bacteriano/genética , Edição de Genes/métodos , Humanos
2.
Microbiol Spectr ; 11(6): e0169723, 2023 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-37888989

RESUMO

IMPORTANCE: We have identified a novel phage-encoded inhibitor of the major cytoskeletal protein in bacterial division, FtsZ. The inhibition is shown to confer T5 bacteriophage with a growth advantage in dividing hosts. Our studies demonstrate a strategy in bacteriophages to maximize their progeny number by inhibiting escape of one of the daughter cells of an infected bacterium. They further emphasize that FtsZ is a natural target for bacterial growth inhibition.


Assuntos
Bacteriófagos , Divisão Celular , Bacteriófagos/fisiologia , Bactérias , Proteínas do Citoesqueleto , Proteínas de Bactérias/genética
3.
RNA Biol ; 20(1): 830-835, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-37846029

RESUMO

Most recently developed phage engineering technologies are based on the CRISPR-Cas system. Here, we present a non-CRISPR-based method for genetically engineering the Escherichia coli phages T5, T7, P1, and λ by adapting the pORTMAGE technology, which was developed for engineering bacterial genomes. The technology comprises E. coli harbouring a plasmid encoding a potent recombinase and a gene transiently silencing a repair system. Oligonucleotides with the desired phage mutation are electroporated into E. coli followed by infection of the target bacteriophage. The high efficiency of this technology, which yields 1-14% of desired recombinants, allows low-throughput screening for the desired mutant. We have demonstrated the use of this technology for single-base substitutions, for deletions of 50-201 bases, for insertions of 20 bases, and for four different phages. The technology may also be readily modified for use across many additional bacterial and phage strains.[Figure: see text].


Assuntos
Bacteriófagos , Bacteriófagos/genética , Escherichia coli/genética , Sistemas CRISPR-Cas , Mutação , Tecnologia
4.
Nucleic Acids Res ; 51(14): 7552-7562, 2023 08 11.
Artigo em Inglês | MEDLINE | ID: mdl-37326009

RESUMO

Natural prokaryotic defense via the CRISPR-Cas system requires spacer integration into the CRISPR array in a process called adaptation. To search for adaptation proteins with enhanced capabilities, we established a robust perpetual DNA packaging and transfer (PeDPaT) system that uses a strain of T7 phage to package plasmids and transfer them without killing the host, and then uses a different strain of T7 phage to repeat the cycle. We used PeDPaT to identify better adaptation proteins-Cas1 and Cas2-by enriching mutants that provide higher adaptation efficiency. We identified two mutant Cas1 proteins that show up to 10-fold enhanced adaptation in vivo. In vitro, one mutant has higher integration and DNA binding activities, and another has a higher disintegration activity compared to the wild-type Cas1. Lastly, we showed that their specificity for selecting a protospacer adjacent motif is decreased. The PeDPaT technology may be used for many robust screens requiring efficient and effortless DNA transduction.


Assuntos
Proteínas Associadas a CRISPR , Proteínas de Escherichia coli , Escherichia coli , Proteínas Associadas a CRISPR/genética , Proteínas Associadas a CRISPR/metabolismo , Sistemas CRISPR-Cas , DNA/genética , DNA/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/metabolismo , Plasmídeos/genética
5.
Proc Natl Acad Sci U S A ; 118(23)2021 06 08.
Artigo em Inglês | MEDLINE | ID: mdl-34074772

RESUMO

Bacteriophages (phages) have evolved efficient means to take over the machinery of the bacterial host. The molecular tools at their disposal may be applied to manipulate bacteria and to divert molecular pathways at will. Here, we describe a bacterial growth inhibitor, gene product T5.015, encoded by the T5 phage. High-throughput sequencing of genomic DNA of bacterial mutants, resistant to this inhibitor, revealed disruptive mutations in the Escherichia coli ung gene, suggesting that growth inhibition mediated by T5.015 depends on the uracil-excision activity of Ung. We validated that growth inhibition is abrogated in the absence of ung and confirmed physical binding of Ung by T5.015. In addition, biochemical assays with T5.015 and Ung indicated that T5.015 mediates endonucleolytic activity at abasic sites generated by the base-excision activity of Ung. Importantly, the growth inhibition resulting from the endonucleolytic activity is manifested by DNA replication and cell division arrest. We speculate that the phage uses this protein to selectively cause cleavage of the host DNA, which possesses more misincorporated uracils than that of the phage. This protein may also enhance phage utilization of the available resources in the infected cell, since halting replication saves nucleotides, and stopping cell division maintains both daughters of a dividing cell.


Assuntos
Bacteriófagos/genética , Bacteriófagos/fisiologia , DNA/metabolismo , Nucleotídeos de Desoxiuracil/metabolismo , Pontos de Checagem do Ciclo Celular , Divisão Celular , Endonucleases , Escherichia coli/genética , Sequenciamento de Nucleotídeos em Larga Escala , Mutação , Uracila/metabolismo
6.
Nucleic Acids Res ; 45(13): 7697-7707, 2017 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-28486695

RESUMO

Infection of Escherichia coli by the T7 phage leads to rapid and selective inhibition of the bacterial RNA polymerase (RNAP) by the 7 kDa T7 protein Gp2. We describe the identification and functional and structural characterisation of a novel 7 kDa T7 protein, Gp5.7, which adopts a winged helix-turn-helix-like structure and specifically represses transcription initiation from host RNAP-dependent promoters on the phage genome via a mechanism that involves interaction with DNA and the bacterial RNAP. Whereas Gp2 is indispensable for T7 growth in E. coli, we show that Gp5.7 is required for optimal infection outcome. Our findings provide novel insights into how phages fine-tune the activity of the host transcription machinery to ensure both successful and efficient phage progeny development.


Assuntos
Bacteriófago T7/metabolismo , Bacteriófago T7/patogenicidade , Proteínas de Ligação a DNA/metabolismo , RNA Polimerases Dirigidas por DNA/metabolismo , Proteínas de Escherichia coli/metabolismo , Escherichia coli/enzimologia , Escherichia coli/virologia , Proteínas Virais/metabolismo , Bacteriófago T7/genética , Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/genética , Modelos Moleculares , Mutagênese , Dobramento de Proteína , Eletricidade Estática , Proteínas Virais/química , Proteínas Virais/genética
7.
Mol Cell ; 66(5): 721-728.e3, 2017 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-28552617

RESUMO

A major limitation in using bacteriophage-based applications is their narrow host range. Approaches for extending the host range have focused primarily on lytic phages in hosts supporting their propagation rather than approaches for extending the ability of DNA transduction into phage-restrictive hosts. To extend the host range of T7 phage for DNA transduction, we have designed hybrid particles displaying various phage tail/tail fiber proteins. These modular particles were programmed to package and transduce DNA into hosts that restrict T7 phage propagation. We have also developed an innovative generalizable platform that considerably enhances DNA transfer into new hosts by artificially selecting tails that efficiently transduce DNA. In addition, we have demonstrated that the hybrid particles transduce desired DNA into desired hosts. This study thus critically extends and improves the ability of the particles to transduce DNA into novel phage-restrictive hosts, providing a platform for myriad applications that require this ability.


Assuntos
Bacteriófago T7/genética , DNA Bacteriano/genética , DNA Viral/genética , Escherichia coli/genética , Vetores Genéticos , Klebsiella pneumoniae/genética , Shigella sonnei/genética , Transdução Genética/métodos , Vírion , DNA Bacteriano/biossíntese , DNA Viral/biossíntese , Escherichia coli/metabolismo , Escherichia coli/virologia , Regulação Bacteriana da Expressão Gênica , Regulação Viral da Expressão Gênica , Klebsiella pneumoniae/metabolismo , Klebsiella pneumoniae/virologia , Shigella sonnei/metabolismo , Shigella sonnei/virologia
8.
Cell Rep ; 16(11): 2811-2818, 2016 09 13.
Artigo em Inglês | MEDLINE | ID: mdl-27626652

RESUMO

Prokaryotic adaptive immune systems are composed of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins. These systems adapt to new threats by integrating short nucleic acids, termed spacers, into the CRISPR array. The functional motifs in the repeat and the mechanism by which a constant repeat size is maintained are still elusive. Here, through a series of mutations within the repeat of the CRISPR-Cas type I-E, we identify motifs that are crucial for adaptation and show that they serve as anchor sites for two molecular rulers determining the size of the new repeat. Adaptation products from various repeat mutants support a model in which two motifs in the repeat bind to two different sites in the adaptation complex that are 8 and 16 bp away from the active site. This model significantly extends our understanding of the adaptation process and broadens the scope of its applications.


Assuntos
Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas/genética , Sequências Repetitivas de Ácido Nucleico/genética , Sequência de Bases , Escherichia coli/genética , Marcadores Genéticos , Modelos Genéticos , Motivos de Nucleotídeos/genética , Reprodutibilidade dos Testes
9.
Trends Microbiol ; 23(12): 744-746, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26526502

RESUMO

Bacteriophages, bacteria's natural enemies, may serve as potent antibacterial agents. Their specificity for certain bacterial sub-species limits their effectiveness, but allows selective targeting of bacteria. Lu and colleagues present a platform for such targeting through alteration of bacteriophages' host specificity by swapping specificity domains in their host-recognition ligand.


Assuntos
Bactérias/virologia , Infecções Bacterianas/microbiologia , Infecções Bacterianas/terapia , Bacteriófagos/crescimento & desenvolvimento , Terapia Biológica/métodos , Terapias Complementares/métodos , Humanos
10.
Methods Mol Biol ; 1311: 233-50, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25981477

RESUMO

The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated proteins (Cas) comprise a prokaryotic adaptive defense system against foreign nucleic acids. This defense is mediated by Cas proteins, which are guided by sequences flanked by the repeats, called spacers, to target nucleic acids. Spacers designed against the prokaryotic self chromosome are lethal to the prokaryotic cell. This self-killing of the bacterium by its own CRISPR-Cas system can be used to positively select genes that participate in this killing, as their absence will result in viable cells. Here we describe a positive selection assay that uses this feature to identify E. coli mutants encoding an inactive CRISPR-Cas system. The procedure includes establishment of an assay that detects this self-killing, generation of transposon insertion mutants in random genes, and selection of viable mutants, suspected as required for this lethal activity. This procedure enabled us to identify a novel gene, htpG, that is required for the activity of the CRISPR-Cas system. The procedures described here can be adjusted to various organisms to identify genes required for their CRISPR-Cas activity.


Assuntos
Sistemas CRISPR-Cas/genética , Escherichia coli/genética , Genes Bacterianos/genética , Engenharia Genética/métodos , Mutação , Elementos de DNA Transponíveis/genética , Mutagênese , Fenótipo , Reação em Cadeia da Polimerase , Transformação Bacteriana
11.
Nature ; 520(7548): 505-510, 2015 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-25874675

RESUMO

CRISPR-Cas (clustered, regularly interspaced short palindromic repeats coupled with CRISPR-associated proteins) is a bacterial immunity system that protects against invading phages or plasmids. In the process of CRISPR adaptation, short pieces of DNA ('spacers') are acquired from foreign elements and integrated into the CRISPR array. So far, it has remained a mystery how spacers are preferentially acquired from the foreign DNA while the self chromosome is avoided. Here we show that spacer acquisition is replication-dependent, and that DNA breaks formed at stalled replication forks promote spacer acquisition. Chromosomal hotspots of spacer acquisition were confined by Chi sites, which are sequence octamers highly enriched on the bacterial chromosome, suggesting that these sites limit spacer acquisition from self DNA. We further show that the avoidance of self is mediated by the RecBCD double-stranded DNA break repair complex. Our results suggest that, in Escherichia coli, acquisition of new spacers largely depends on RecBCD-mediated processing of double-stranded DNA breaks occurring primarily at replication forks, and that the preference for foreign DNA is achieved through the higher density of Chi sites on the self chromosome, in combination with the higher number of forks on the foreign DNA. This model explains the strong preference to acquire spacers both from high copy plasmids and from phages.


Assuntos
Adaptação Fisiológica , Bacteriófagos/genética , Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas/genética , DNA Bacteriano/genética , DNA Viral/genética , Escherichia coli/genética , Plasmídeos/genética , Sistemas CRISPR-Cas/genética , Sequência Consenso/genética , Quebras de DNA de Cadeia Dupla , Reparo do DNA , Replicação do DNA/genética , Exodesoxirribonuclease V/metabolismo , Modelos Biológicos
12.
Biochem Soc Trans ; 41(6): 1412-5, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24256229

RESUMO

The CRISPRs (clustered regularly interspaced short palindromic repeats) and their associated Cas (CRISPR-associated) proteins are a prokaryotic adaptive defence system against foreign nucleic acids. The CRISPR array comprises short repeats flanking short segments, called 'spacers', which are derived from foreign nucleic acids. The process of spacer insertion into the CRISPR array is termed 'adaptation'. Adaptation allows the system to rapidly evolve against emerging threats. In the present article, we review the most recent studies on the adaptation process, and focus primarily on the subtype I-E CRISPR-Cas system of Escherichia coli.


Assuntos
Sistemas CRISPR-Cas/genética , Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas/genética , Escherichia coli/genética , Adaptação Fisiológica
13.
Proc Natl Acad Sci U S A ; 110(35): 14396-401, 2013 Aug 27.
Artigo em Inglês | MEDLINE | ID: mdl-23940313

RESUMO

Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated proteins constitute a recently identified prokaryotic defense system against invading nucleic acids. DNA segments, termed protospacers, are integrated into the CRISPR array in a process called adaptation. Here, we establish a PCR-based assay that enables evaluating the adaptation efficiency of specific spacers into the type I-E Escherichia coli CRISPR array. Using this assay, we provide direct evidence that the protospacer adjacent motif along with the first base of the protospacer (5'-AAG) partially affect the efficiency of spacer acquisition. Remarkably, we identified a unique dinucleotide, 5'-AA, positioned at the 3' end of the spacer, that enhances efficiency of the spacer's acquisition. Insertion of this dinucleotide increased acquisition efficiency of two different spacers. DNA sequencing of newly adapted CRISPR arrays revealed that the position of the newly identified motif with respect to the 5'-AAG is important for affecting acquisition efficiency. Analysis of approximately 1 million spacers showed that this motif is overrepresented in frequently acquired spacers compared with those acquired rarely. Our results represent an example of a short nonprotospacer adjacent motif sequence that affects acquisition efficiency and suggest that other as yet unknown motifs affect acquisition efficiency in other CRISPR systems as well.


Assuntos
Adaptação Fisiológica/genética , DNA Bacteriano/genética , Escherichia coli/genética , Motivos de Nucleotídeos , Escherichia coli/fisiologia
14.
J Mol Biol ; 423(1): 14-6, 2012 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-22771574

RESUMO

We analyzed sequences of newly inserted repeats in an Escherichia coli CRISPR (clustered regularly interspaced short palindromic repeats) array in vivo and showed that a base previously thought to belong to the repeat is actually derived from a protospacer. Based on further experimental results, we propose to use the term "duplicon" for a repeated sequence in a CRISPR array that serves as a template for a new duplicon. Our findings suggest the possibility of redrawing the borders between repeats, spacers, and protospacer adjacent motifs.


Assuntos
Escherichia coli/genética , Sequências Repetidas Invertidas/genética , Sequência de Bases , Dados de Sequência Molecular , Duplicações Segmentares Genômicas/genética
15.
Nucleic Acids Res ; 40(12): 5569-76, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22402487

RESUMO

The clustered regularly interspaced short palindromic repeats and their associated proteins (CRISPR/Cas) constitute a recently identified prokaryotic defense mechanism against invading nucleic acids. Activity of the CRISPR/Cas system comprises of three steps: (i) insertion of alien DNA sequences into the CRISPR array to prevent future attacks, in a process called 'adaptation', (ii) expression of the relevant proteins, as well as expression and processing of the array, followed by (iii) RNA-mediated interference with the alien nucleic acid. Here we describe a robust assay in Escherichia coli to explore the hitherto least-studied process, adaptation. We identify essential genes and DNA elements in the leader sequence and in the array which are essential for the adaptation step. We also provide mechanistic insights on the insertion of the repeat-spacer unit by showing that the first repeat serves as the template for the newly inserted repeat. Taken together, our results elucidate fundamental steps in the adaptation process of the CRISPR/Cas system.


Assuntos
DNA Bacteriano/química , Proteínas de Escherichia coli/metabolismo , Escherichia coli/genética , Sequências Repetidas Invertidas , Adaptação Fisiológica , Escherichia coli/metabolismo , Motivos de Nucleotídeos
16.
Proc Natl Acad Sci U S A ; 108(50): 20136-41, 2011 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-22114197

RESUMO

Prokaryotic DNA arrays arranged as clustered regularly interspaced short palindromic repeats (CRISPR), along with their associated proteins, provide prokaryotes with adaptive immunity by RNA-mediated targeting of alien DNA or RNA matching the sequences between the repeats. Here, we present a thorough screening system for the identification of bacterial proteins participating in immunity conferred by the Escherichia coli CRISPR system. We describe the identification of one such protein, high-temperature protein G (HtpG), a homolog of the eukaryotic chaperone heat-shock protein 90. We demonstrate that in the absence of htpG, the E. coli CRISPR system loses its suicidal activity against λ prophage and its ability to provide immunity from lysogenization. Transcomplementation of htpG restores CRISPR activity. We further show that inactivity of the CRISPR system attributable to htpG deficiency can be suppressed by expression of Cas3, a protein that is essential for its activity. Accordingly, we also find that the steady-state level of overexpressed Cas3 is significantly enhanced following HtpG expression. We conclude that HtpG is a newly identified positive modulator of the CRISPR system that is essential for maintaining functional levels of Cas3.


Assuntos
Proteínas de Escherichia coli/metabolismo , Escherichia coli/genética , Proteínas de Choque Térmico HSP90/metabolismo , Temperatura Alta , Sequências Repetidas Invertidas/genética , Escherichia coli/metabolismo , Escherichia coli/virologia , Proteínas de Escherichia coli/genética , Regulação Bacteriana da Expressão Gênica , Genes Bacterianos/genética , Testes Genéticos , Proteínas de Choque Térmico HSP90/genética , Mutação/genética , Plasmídeos/genética , Prófagos/metabolismo , Reprodutibilidade dos Testes
18.
Emerg Infect Dis ; 16(6): 1014-7, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20507761
19.
Antimicrob Agents Chemother ; 54(6): 2687-91, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20231393

RESUMO

All of the carbapenem-resistant Escherichia coli (CREC) isolates identified in our hospital from 2005 to 2008 (n = 10) were studied. CREC isolates were multidrug resistant, all carried bla(KPC-2), and six of them were also extended-spectrum beta-lactamase producers. Pulsed-field gel electrophoresis indicated six genetic clones; within the same clone, similar transferable bla(KPC-2)-containing plasmids were found whereas plasmids differed between clones. Tn4401 elements were identified in all of these plasmids.


Assuntos
Carbapenêmicos/farmacologia , Infecções por Escherichia coli/tratamento farmacológico , Infecções por Escherichia coli/microbiologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , beta-Lactamases/biossíntese , beta-Lactamases/genética , Centros Médicos Acadêmicos , Proteínas de Bactérias/biossíntese , Proteínas de Bactérias/genética , Sequência de Bases , Primers do DNA/genética , Farmacorresistência Bacteriana Múltipla/genética , Eletroforese em Gel de Campo Pulsado , Escherichia coli/enzimologia , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/epidemiologia , Humanos , Técnicas In Vitro , Israel/epidemiologia , Testes de Sensibilidade Microbiana , Epidemiologia Molecular , Plasmídeos/genética , Fatores de Tempo
20.
Antimicrob Agents Chemother ; 54(7): 3002-6, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20350950

RESUMO

Sporadic isolates of carbapenem-resistant KPC-2-producing Klebsiella pneumoniae were isolated in Tel Aviv Medical Center during 2005 and 2006, parallel to the emergence of the KPC-3-producing K. pneumoniae sequence type 258 (ST 258). We aimed to study the molecular epidemiology of these isolates and to characterize their bla(KPC)-carrying plasmids and their origin. Ten isolates (8 KPC-2 and 2 KPC-3 producing) were studied. All isolates were extremely drug resistant. They possessed the bla(KPC) gene and varied in their additional beta-lactamase contents. The KPC-2-producing strains belonged to three different sequence types: ST 340 (n = 2), ST 277 (n = 2), and a novel sequence type, ST 376 (n = 4). Among KPC-3-producing strains, a single isolate (ST 327) different from ST 258 was identified, but both strains carried the same plasmid (pKpQIL). The KPC-2-encoding plasmids varied in size (45 to 95 kb) and differed among each of the STs. Two of the Klebsiella bla(KPC-2)-carrying plasmids were identical to plasmids from Escherichia coli, suggesting a common origin of these plasmids. These data indicate that KPC evolution in K. pneumoniae is related to rare events of interspecies spread of bla(KPC-2)-carrying plasmids from E. coli followed by limited clonal spread, whereas KPC-3 carriage in this species is related almost strictly to clonal expansion of ST 258 carrying pKpQIL.


Assuntos
Klebsiella pneumoniae/enzimologia , Klebsiella pneumoniae/genética , Epidemiologia Molecular/métodos , Plasmídeos/genética , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Carbapenêmicos/uso terapêutico , Farmacorresistência Bacteriana/genética , Humanos , Israel/epidemiologia , Infecções por Klebsiella/tratamento farmacológico , Infecções por Klebsiella/microbiologia , Klebsiella pneumoniae/classificação , Klebsiella pneumoniae/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Filogenia , Reação em Cadeia da Polimerase , beta-Lactamases/genética , beta-Lactamases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...